NEW YORK–(BUSINESS WIRE)–Kirby McInerney LLP reminds investors who purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE:PRGO) securities to contact NEW YORK–(BUSINESS WIRE)–Kirby McInerney LLP reminds investors who purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE:PRGO) securities to contact

PRGO: Kirby McInerney LLP Advises Perrigo Company plc Investors of Class Action Lawsuit

2026/01/03 09:15
3분 읽기
이 콘텐츠에 대한 의견이나 우려 사항이 있으시면 crypto.news@mexc.com으로 연락주시기 바랍니다

NEW YORK–(BUSINESS WIRE)–Kirby McInerney LLP reminds investors who purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE:PRGO) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.

If you suffered a loss on your Perrigo investments, you have until January 16, 2026 to request lead plaintiff appointment. Follow the link below for more information:

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is The Lawsuit About?

The lawsuit has been filed on behalf of investors who purchased securities during the period of February 27, 2023 through November 4, 2025, inclusive (“the Class Period”). The lawsuit alleges that Perrigo made materially false and/or misleading statements and/or failed to disclose to investors: (1) that the infant formula business acquired from Nestle suffered from significant underinvestment in maintenance, operational improvements, and repairs; (2) that Perrigo needed to make substantial capital and operational expenditures above the Company’s outwardly stated cost estimates to remediate the infant formula business; (3) that there were significant manufacturing deficiencies in the facility for the Company’s infant formula business; and (4) that, as a result of the foregoing, the Company’s financial results, including earnings and cash flow, were overstated.

On November 5, 2025, Perrigo released its third quarter 2025 financial results and lowered its full year guidance “due to soft OTC consumption & infant formula dynamics.” The Company also disclosed it was “initiating a strategic review of its infant formula business” including “reassessing the Company’s previously announced investment in this business of $240 million.” On this news, the price of Perrigo shares declined by $5.09 per share, or approximately 25.2%, from $20.19 per share on November 4, 2025 to close at $15.10 on November 5, 2025.

[CLICK HERE TO LEARN MORE ABOUT THE CLASS ACTION]

What Should I Do?

If you purchased or otherwise acquired Perrigo securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[HOW CAN I PROTECT MY RIGHTS?]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP

Lauren Molinaro, Esq.

212-699-1171

https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

시장 기회
FORM 로고
FORM 가격(FORM)
$0.253
$0.253$0.253
-3.58%
USD
FORM (FORM) 실시간 가격 차트
면책 조항: 본 사이트에 재게시된 글들은 공개 플랫폼에서 가져온 것으로 정보 제공 목적으로만 제공됩니다. 이는 반드시 MEXC의 견해를 반영하는 것은 아닙니다. 모든 권리는 원저자에게 있습니다. 제3자의 권리를 침해하는 콘텐츠가 있다고 판단될 경우, crypto.news@mexc.com으로 연락하여 삭제 요청을 해주시기 바랍니다. MEXC는 콘텐츠의 정확성, 완전성 또는 시의적절성에 대해 어떠한 보증도 하지 않으며, 제공된 정보에 기반하여 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다. 본 콘텐츠는 금융, 법률 또는 기타 전문적인 조언을 구성하지 않으며, MEXC의 추천이나 보증으로 간주되어서는 안 됩니다.

USD1 Genesis: 0 Fees + 12% APR

USD1 Genesis: 0 Fees + 12% APRUSD1 Genesis: 0 Fees + 12% APR

New users: stake for up to 600% APR. Limited time!